Who Owns KTTA?

Pasithea Therapeutics Corp. — Institutional Ownership & 13F Holdings

$0.70

+0.01 (+1.98%)

Market Cap

$6.0M

Shares Outstanding

7,442,153

Institutional Holders

8

Total Inst. Value

$99K

% of Float Held

QoQ Holder Change

+1

Institutional data as of Q1 2025

New Positions

3

Closed Positions

3

Increased

1

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1AdvisorShares Investments LLCNew$66K53,547
2CITIGROUP INCNew$18K13,706
3UBS Group AG$6K4,337
4Hurley Capital, LLCNew$5K3,689
5Tower Research Capital LLC (TRC)$4K3,267
6ROYAL BANK OF CANADA$0250
7JPMORGAN CHASE & CO$0150
8BANK OF AMERICA CORP /DE/$08

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
UBS Group AG-9K$6K

Related Stocks

Frequently Asked Questions

How many institutional investors hold KTTA?

As of Q1 2025, 8 institutional investors report holding KTTA (Pasithea Therapeutics Corp.) in their 13F filings.

Which hedge fund owns the most KTTA?

The largest institutional holder of KTTA is AdvisorShares Investments LLC with $66K in shares.

Are institutions buying or selling KTTA?

This quarter, 3 institutions opened new positions in KTTA and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.